IssuerAnnouncementDetailsV2Portlet
Actions
Amana Cooperative Insurance Co. Announces the Results of the Ordinary General Assembly Meeting, ( First Meeting )
| Element List | Explanation |
|---|---|
| Introduction | Amana Cooperative Insurance announces the results of the Ordinary General Assembly meeting (the second meeting) due to the lack of a quorum in the first meeting, The second meeting was held an hour after the first meeting, with the quorum required for its convening , This is done through modern technology through Tadawulaty |
| City and Location of the General Assembly's Meeting | The company's headquarters in Riyadh - through modern technology |
| Date of the General Assembly's Meeting | 2023-06-22 Corresponding to 1444-12-04 |
| Time of the General Assembly's Meeting | 20:30 |
| Percentage of Attending Shareholders | 16.43% |
| Names of the Board of Directors' Members Present at the General Assembly's Meeting and Names of the Absentees | The meeting was attended by the following members of the Board of Directors: 1- Dr. Abdullah bin Othman Al-Musa (Chairman). 2- Mr. Tariq bin Abdullah Al-Qarawi (Vice-Chsirman). 3 Mr. Naif bin Faisal Al-Sudairy (Member). 4- Mr. Abdulrahman Abdullah Al-Sakran (Member). 5- Mr. Hassan Rumaih Al-Zahrani (Member). 6- Mr. Rasheed Salim Abi Nader (Member). 7- Mr. Bashar Talal Kayali (Member). |
| Names of the Chairmen of the Committees Present at the General Assembly's Meeting or Members of such Committees Attending on Their Behalf | Mr. Tariq Abdullah Al-Qarawi - (Chairman of the Executive Committee) Mr. Abdul Rahman Abdullah Al-Sakran - (Chairman of the Risk Committee) Mr. Naif Faisal Al-Sudairi - (Chairman of the Nominations and Remunerations Committee) Mr. Rachid Salim Abi Nader - (Chairman of the Investment Committee) Mr. Bashar Talal Kayali (Member). |
| Voting Results on the Items of the General Assembly's Meeting Agenda's | 1. Reviewed and discussed the report of the Board of Directors for the fiscal year ending on 12/31/2022G. 2. Reviewed and discussed the financial report for the fiscal year ending on 12/31/2022G. 3. Approval on the company's auditors' report for the fiscal year ending on 12/31/2022 G. 4. Approval to absolve the members of the Board of Directors from liability for the fiscal year ending on 12/31/2022 G. 5. Approval on the appointment of the company's auditors based on the Audit Committee. This is to examine, review and audit the financial statements for the second, third, fourth and annual quarters of the fiscal year 2023 AD and the first quarter of 2024 AD and determine their fees. 6. Approval on the disbursement of an amount of 746,000.01 Saudi riyals as bonuses for members of the Board of Directors for the fourth session ending on 05/15/2022 AD. 7. Approval on the disbursement of an amount of 639,833.32 riyals as bonuses for members of the Board of Directors for the current session for the fiscal year ending on 12/31/2022 G. 8. Approval on the business and contracts concluded or that will be concluded between the Company and GlobeMed Saudi, in which the Board members Mr. Naif Alsudairy, Mr. Pierre Pharaon and Mr. Abdulrahman Alsakran have an indirect interest. This business and contract is medical claims management contract for year 2022G of SAR (5,677,000) without special conditions or benefits. 9. Approval on the works and contracts that were appointed between the companies and the owner companies, which are property contracts, and claims. The value of transactions for the previous year 2022 G is (677,000) Saudi riyals. without special conditions or benefits. |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
Share
Company Performance
Key Parameters
Last Price 12.98
Net Change -0.08 (-0.61%)
Value Traded (Sar) 8,196,365.28
Volume Traded 633,467
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions